Nina Talayco, MS OTRL | |
124 Watertown St, Watertown, MA 02472-2576 | |
(617) 923-4410 | |
(617) 923-0468 |
Full Name | Nina Talayco |
---|---|
Gender | Female |
Speciality | Occupational Therapist - Pediatrics |
Location | 124 Watertown St, Watertown, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194863761 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225XP0200X | Occupational Therapist - Pediatrics | 9216 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Nina Talayco, MS OTRL 30 Miland Ave, Chelmsford, MA 01824-2249 Ph: (978) 251-4345 | Nina Talayco, MS OTRL 124 Watertown St, Watertown, MA 02472-2576 Ph: (617) 923-4410 |
News Archive
The U.S. Food and Drug Administration (FDA) today approved Besponsa (inotuzumab ozogamicin) in the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) - a rare form of ALL.
The U.S. Department of Health and Human Services today announced new steps to reduce premiums and make it easier for Americans to enroll in the Pre-Existing Condition Insurance Plan. Premiums for the Federally-administered Pre-Existing Condition Insurance Plan will drop as much as 40 percent in 18 States, and eligibility standards will be eased in 23 States and the District of Columbia to ensure more Americans with pre-existing conditions have access to affordable health insurance.
Second-hand smoke is associated with a number of diseases and conditions, including cancer, heart disease, and emphysema. It is an irritant to lung tissue and blood vessels, but the processes through which the body reacts to second-hand smoke comprise a mystery scientists are only beginning to unravel. Researchers at the University of Colorado-Denver are currently studying how second-hand smoke affects the lungs of rats, and so far it appears that second-hand smoke triggers a complex inflammatory response.
A cancer drug in the process of being developed by two Australian companies has shown promising results in preliminary trials on animals.
For most patients with chronic kidney disease (CKD), the risk of experiencing a cardiovascular related death is greater than the risk of progressing to end-stage renal disease (ESRD).
› Verified 6 days ago
Dori Fishbone, MS OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 124 Watertown St, Watertown, MA 02472 Phone: 617-923-4410 Fax: 617-923-0468 | |
Melanie Allen-salort, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 124 Watertown St, Watertown, MA 02472 Phone: 617-923-4410 Fax: 617-923-0468 | |
Margaret Eleanor Meyer, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 124 Watertown St, Watertown, MA 02472 Phone: 617-923-4410 Fax: 617-923-0468 | |
Kori B Constantian, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 124 Watertown St, Watertown, MA 02472 Phone: 617-923-4410 Fax: 617-923-0468 | |
Mrs. Abigail Sara Murphy, M.S. OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 124 Watertown St, Watertown, MA 02472 Phone: 617-923-4410 | |
Lori Goodrich, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 124 Watertown St, Watertown, MA 02472 Phone: 617-923-4410 Fax: 617-923-0468 |